SavedAdd your journal

Journals / Turkish Journal of Pediatrics / 2018 / Cilt: 60 - Sayı: 5

Epigenotype and phenotype correlations in patients with Beckwith-Wiedemann syndrome

Burçak BİLGİN
Serkan Kabaçam
Ekim TAŞKIRAN
Pelin Özlem ŞİMŞEK-KİPER
YASEMİN ALANAY
Koray BODUROĞLU
Gülen Eda UTİNE
Pages
506–513
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Anticipating follow-up isclinically important in BWS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Beckwith-Wiedemann Syndrome (BWS) is one of the most common overgrowthsyndromes.
📊
Key Findings & Data:This study was performed to detect the molecularetiology in 28 patients with BWS, to search for epigenotype-phenotypecorrelations and to provide appropriate individualized multidisciplinaryapproach.
💡
Conclusion & Impact:Anticipating follow-up isclinically important in BWS.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Beckwith-Wiedemann Syndrome (BWS) is one of the most common overgrowthsyndromes. Cancer predisposition is an important feature of this clinicallyheterogeneous syndrome. Patients may have fetal and early childhoodovergrowth, hemihyperplasia, macroglossia, facial dysmorphic features,abdominal wall defects, visceromegaly, and anomalies of the heart and thekidneys. Various previous investigations showed that heterogeneous molecularetiology may contribute to clinical variability and that epigenotype-phenotypecorrelations exist in BWS. This study was performed to detect the molecularetiology in 28 patients with BWS, to search for epigenotype-phenotypecorrelations and to provide appropriate individualized multidisciplinaryapproach. Four different molecular etiology groups were determined based ontesting for copy number analysis and methylation status at 11p15. Sequencingfor CDKN1C mutations were also performed. Groups were compared for variousclinical findings. Differences between groups were not statistically significantowing to the small number of patients in individual groups. Statisticalstudies for epigenotype-phenotype correlations showed significance for onlyanterior ear lobe creases, visceromegaly and embryonal tumors. Additionally,one interesting patient had a mesenchymal tumor. Anticipating follow-up isclinically important in BWS.

🔖

Cite This Article

BİLGİN, B., Kabaçam, S., TAŞKIRAN, E., ŞİMŞEK-KİPER, P. Ö., ALANAY, Y., BODUROĞLU, K., UTİNE, G. E. (2018). Epigenotype and phenotype correlations in patients with Beckwith-Wiedemann syndrome. Turkish Journal of Pediatrics, Cilt: 60 - Sayı: 5, 506–513. https://ajindex.com/articles/412120

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Thorburn MJ, Wright ES, Miller CG, Smith-Read EH. Exomphalos-macroglossia-gigantism syndrome in Jamaican infants. Am J Dis Child 1970; 119: 316-321
  2. Engström W, Lindham S, Schofield P. WiedemannBeckwith syndrome. Eur J Pediatr 1988; 147: 450-457
  3. Greer KJ, Kirkpatrick SJ, Weksberg R, Pauli RM. Beckwith-Wiedemann syndrome in adults: Observations from one family and recommendations for care. Am J Med Genet Part A 2008; 146A: 1707-1712
  4. Weksberg R, Shuman C, Smith AC. BeckwithWiedemann syndrome. Am J Med Genet Part C Semin Med Genet 2005; 137C: 12-23
  5. Cohen MM, Jr. Beckwith-Wiedemann syndrome: Historical, clinicopathological, and etiopathogenetic perspectives. Pediatr Dev Pathol 2005; 8: 287-304
  6. Rump P, Zeegers MP, van Essen AJ. Tumor risk in Beckwith-Wiedemann syndrome: A review and metaanalysis. Am J Med Genet Part A 2005; 136: 95-104
  7. Cohen MM, Jr. Overgrowth syndromes: An update. Adv Pediatr 1999; 46: 441-491
  8. Maher ER, Reik W. Beckwith-Wiedemann syndrome: Imprinting in clusters revisited. J Clin Invest 2000; 105: 247-252
  9. Choufani S, Shuman C, Weksberg R. BeckwithWiedemann syndrome. Am J Med Genet C Semin Med Genet 2010; 154C: 343-354
  10. Elliott M, Maher ER. Beckwith-Wiedemann syndrome. J Med Genet 1994; 31: 560-564
  11. Tan TY, Amor DJ. Tumour surveillance in BeckwithWiedemann syndrome and hemihyperplasia: A critical review of the evidence and suggested guidelines for local practice. J Paediatr Child Health 2006; 42: 486-490
  12. Wiedemann HR. Tumours and hemihypertrophy associated with Wiedemann-Beckwith syndrome. Eur J Pediatr 1983; 141: 129
  13. Bliek J, Maas SM, Ruijter JM, et al. Increased tumour risk for BWS patients correlates with aberrant H19 and not KCNQ1OT1 methylation: Occurrence of KCNQ1OT1 hypomethylation in familial cases of BWS. Hum Mol Genet 2001; 10: 467-476
  14. Cooper WN, Luharia A, Evans GA, et al. Molecular subtypes and phenotypic expression of BeckwithWiedemann syndrome. Eur J Hum Genet 2005; 13: 1025-1032
  15. Weksberg R, Shuman C, Beckwith JB. BeckwithWiedemann syndrome. Eur J Hum Genet 2010; 18: 8-14
  16. Weksberg R, Smith AC, Squire J, Sadowski P. Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development. Hum Mol Genet 2003; 12: R61-R68
  17. Elliott M, Bayly R, Cole T, Temple IK, Maher ER. Clinical features and natural history of BeckwithWiedemann syndrome: Presentation of 74 new cases. Clin Genet 1994; 46: 168-174
  18. Weng EY, Moeschler JB, Graham JM Jr. Longit